Skip to main content

Usana Health Sciences Value Stock - Dividend - Research Selection

Usana health sciences

ISIN: US90328M1071 , WKN: 923145

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

General

 

USANA Health Sciences, Inc., a Utah corporation, was founded in 1992 by Myron W. Wentz, Ph.D. We develop and manufacture high-quality, science-based nutritional and personal care products with a primary focus on promoting long-term health and reducing the risk of chronic degenerative disease. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 19 markets worldwide, where we distribute and sell our products by way of direct selling. We have chosen this distribution method as we believe it is the most conducive to meeting our vision as a company, which is improving the overall health and nutrition of individuals and families around the world. Our net sales in fiscal year 2014 were $790.5 million, of which 81.8% were in markets outside of the United States. As a U.S.-based multi-national company with an expanding international presence, our operating results are sensitive to currency fluctuations, as well as economic and political conditions in markets throughout the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we sell and to our method of distribution.

 

Our customer base comprises two types of customers: "Associates" and "Preferred Customers." Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. As of January 3, 2015, we had 349,000 active Associates and 81,000 active Preferred Customers worldwide.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


USANA Health Sciences (USNA) Price Target Decreased by 35.90% to 25.50

2026-08-28

12 Consumer Staples Stocks Moving In Thursday's After-Market Session

2026-08-27
Gainers Farmmi (NASDAQ:FAMI) shares rose 24.3% to $0.13 during Thursday's after-market session. The company's market cap stands at $3.8 million. IP Strategy Holdings (NASDAQ:IPST) stock moved upwards by 11.67%

Which stocks are moving on Wednesday?

2026-08-05
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)

2026-08-05
USANA (USNA) stock sank after weak Q2 earnings. See why its core business is shrinking, growth brands faltered, and a $18.1 fair value estimate—read now.

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

2026-08-05
USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call August 5, 2026 11:00 AM EDTCompany ParticipantsAndrew Masuda - Director of Investor RelationsKevin...

USANA Health Sciences (NYSE:USNA) Shares Tumble as Q2 Results Miss and Guidance Slashed

2026-08-05
USANA shares plunge ~20% after Q2 miss, impairment charge, and slashed 2026 guidance with net sales forecast below consensus.

Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $1.95-$2.29 to $0.76 vs $2.12 Est; Lowers FY2026 Sales Guidance from $925.000M-$1.000B to $910.000M vs $945.097M Est

2026-08-04
Usana Health Sciences (NYSE:USNA) lowers FY2026 Adj EPS guidance from $1.95-$2.29 to $0.76 vs $2.12 analyst estimate. Lowers FY2026 sales outlook from $925.000 million-$1.000 billion to $910.000 million vs $945.097

Usana Health Sciences Q2 Adj. EPS $(0.07) Misses $0.43 Estimate, Sales $223.273M Miss $235.003M Estimate

2026-08-04
Usana Health Sciences (NYSE:USNA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.43 by 116.28 percent. This is a 109.46 percent decrease over earnings of $0.74 per share

USANA Extends Nordiq Canada Partnership Through 2030 Winter Games

2026-07-20
USANA Health Sciences, Inc. (NYSE:USNA), a global leader in science-based nutrition, today announced a renewal of its official partnership with Nordiq Canada, the national governing body for cross-country skiing in

USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy

2026-06-18
See more on USANA’s restructuring, Rise Wellness’ margin reset, and Hiya’s CAC headwinds—plus a USNA Buy call with $30.8 target and valuation upside.